drugset / Trial / NCT03326505

Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment

NCT03326505

Phase 1/2 Completed 60 enrolled University of Jordan
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims at expanding Umbilical Cord derived Mesenchymal Stem Cells (MSCs) to a clinical scale according to Good Laboratory Practice and study its efficacy when compared to a Supervised Physical Therapy Program alone.

Timeline

Start
2017-09-25
Primary completion
2020-01-25
Completion
2020-02-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator mesenchymal stem cells Cell therapy Intrathecal

Indications